1,301
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment

ORCID Icon &
Pages 2499-2510 | Received 23 Mar 2021, Accepted 26 May 2021, Published online: 09 Jun 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.